2018-2023 Global Nucleic Acid-based Therapeutics Market Report (Status and Outlook)

October 2018 | 116 pages | ID: 272100E6AF0EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Nucleic Acid-based Therapeutics market for 2018-2023.

Gene therapy is a technique for correcting defective genes responsible for disease development. Nucleic acid-based molecules (deoxyribonucleic acid, complementary deoxyribonucleic acid, complete genes, ribonucleic acid, and oligonucleotides) are utilized as research tools within the broad borders of gene therapy and the emerging field of molecular medicine.
Although most of the nucleic acid-based drugs are in early stages of clinical trials, these classes of compounds have emerged in recent years to yield extremely promising candidates for drug therapy to a wide range of diseases, including cancer, infectious diseases, diabetes, cardiovascular, inflammatory, and neurodegenerative diseases, cystic fibrosis, hemophilia, and other genetic disorders.
Over the next five years, LPI(LP Information) projects that Nucleic Acid-based Therapeutics will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Nucleic Acid-based Therapeutics market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• Anti-Sense And Anti-Gene
• Short Inhibitory Sequences
• Nucleoside Analogs
• Ribozymes
• Aptamers

Segmentation by application:

• Monogenetic Disorders
• Multi-Genetic Disorders

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Wave Life Sciences
• Imugene
• Caperna
• Phylogica
• Protagonist Therapeutics
• Benitec Biopharma
• EGEN
• BioMedica
• Transgene
• Copernicus Therapeutics

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Nucleic Acid-based Therapeutics market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Nucleic Acid-based Therapeutics market by identifying its various subsegments.
• Focuses on the key global Nucleic Acid-based Therapeutics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Nucleic Acid-based Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Nucleic Acid-based Therapeutics submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Nucleic Acid-based Therapeutics Market Size 2013-2023
  2.1.2 Nucleic Acid-based Therapeutics Market Size CAGR by Region
2.2 Nucleic Acid-based Therapeutics Segment by Type
  2.2.1 Anti-Sense And Anti-Gene
  2.2.2 Short Inhibitory Sequences
  2.2.3 Gene Transfer Therapy
  2.2.4 Nucleoside Analogs
  2.2.5 Ribozymes
  2.2.6 Aptamers
2.3 Nucleic Acid-based Therapeutics Market Size by Type
  2.3.1 Global Nucleic Acid-based Therapeutics Market Size Market Share by Type (2013-2018)
  2.3.2 Global Nucleic Acid-based Therapeutics Market Size Growth Rate by Type (2013-2018)
2.4 Nucleic Acid-based Therapeutics Segment by Application
  2.4.1 Monogenetic Disorders
  2.4.2 Multi-Genetic Disorders
2.5 Nucleic Acid-based Therapeutics Market Size by Application
  2.5.1 Global Nucleic Acid-based Therapeutics Market Size Market Share by Application (2013-2018)
  2.5.2 Global Nucleic Acid-based Therapeutics Market Size Growth Rate by Application (2013-2018)

3 GLOBAL NUCLEIC ACID-BASED THERAPEUTICS BY PLAYERS

3.1 Global Nucleic Acid-based Therapeutics Market Size Market Share by Players
  3.1.1 Global Nucleic Acid-based Therapeutics Market Size by Players (2016-2018)
  3.1.2 Global Nucleic Acid-based Therapeutics Market Size Market Share by Players (2016-2018)
3.2 Global Nucleic Acid-based Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 NUCLEIC ACID-BASED THERAPEUTICS BY REGIONS

4.1 Nucleic Acid-based Therapeutics Market Size by Regions
4.2 Americas Nucleic Acid-based Therapeutics Market Size Growth
4.3 APAC Nucleic Acid-based Therapeutics Market Size Growth
4.4 Europe Nucleic Acid-based Therapeutics Market Size Growth
4.5 Middle East & Africa Nucleic Acid-based Therapeutics Market Size Growth

5 AMERICAS

5.1 Americas Nucleic Acid-based Therapeutics Market Size by Countries
5.2 Americas Nucleic Acid-based Therapeutics Market Size by Type
5.3 Americas Nucleic Acid-based Therapeutics Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Nucleic Acid-based Therapeutics Market Size by Countries
6.2 APAC Nucleic Acid-based Therapeutics Market Size by Type
6.3 APAC Nucleic Acid-based Therapeutics Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Nucleic Acid-based Therapeutics by Countries
7.2 Europe Nucleic Acid-based Therapeutics Market Size by Type
7.3 Europe Nucleic Acid-based Therapeutics Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Nucleic Acid-based Therapeutics by Countries
8.2 Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Type
8.3 Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL NUCLEIC ACID-BASED THERAPEUTICS MARKET FORECAST

10.1 Global Nucleic Acid-based Therapeutics Market Size Forecast (2018-2023)
10.2 Global Nucleic Acid-based Therapeutics Forecast by Regions
  10.2.1 Global Nucleic Acid-based Therapeutics Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Nucleic Acid-based Therapeutics Forecast by Type
10.8 Global Nucleic Acid-based Therapeutics Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Wave Life Sciences
  11.1.1 Company Details
  11.1.2 Nucleic Acid-based Therapeutics Product Offered
  11.1.3 Wave Life Sciences Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Wave Life Sciences News
11.2 Imugene
  11.2.1 Company Details
  11.2.2 Nucleic Acid-based Therapeutics Product Offered
  11.2.3 Imugene Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Imugene News
11.3 Caperna
  11.3.1 Company Details
  11.3.2 Nucleic Acid-based Therapeutics Product Offered
  11.3.3 Caperna Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Caperna News
11.4 Phylogica
  11.4.1 Company Details
  11.4.2 Nucleic Acid-based Therapeutics Product Offered
  11.4.3 Phylogica Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Phylogica News
11.5 Protagonist Therapeutics
  11.5.1 Company Details
  11.5.2 Nucleic Acid-based Therapeutics Product Offered
  11.5.3 Protagonist Therapeutics Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Protagonist Therapeutics News
11.6 Benitec Biopharma
  11.6.1 Company Details
  11.6.2 Nucleic Acid-based Therapeutics Product Offered
  11.6.3 Benitec Biopharma Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Benitec Biopharma News
11.7 EGEN
  11.7.1 Company Details
  11.7.2 Nucleic Acid-based Therapeutics Product Offered
  11.7.3 EGEN Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 EGEN News
11.8 BioMedica
  11.8.1 Company Details
  11.8.2 Nucleic Acid-based Therapeutics Product Offered
  11.8.3 BioMedica Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
  11.8.4 Main Business Overview
  11.8.5 BioMedica News
11.9 Transgene
  11.9.1 Company Details
  11.9.2 Nucleic Acid-based Therapeutics Product Offered
  11.9.3 Transgene Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
  11.9.4 Main Business Overview
  11.9.5 Transgene News
11.10 Copernicus Therapeutics
  11.10.1 Company Details
  11.10.2 Nucleic Acid-based Therapeutics Product Offered
  11.10.3 Copernicus Therapeutics Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
  11.10.4 Main Business Overview
  11.10.5 Copernicus Therapeutics News

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Nucleic Acid-based Therapeutics
Figure Nucleic Acid-based Therapeutics Report Years Considered
Figure Market Research Methodology
Figure Global Nucleic Acid-based Therapeutics Market Size Growth Rate 2013-2023 ($ Millions)
Table Nucleic Acid-based Therapeutics Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of Anti-Sense And Anti-Gene
Table Major Players of Short Inhibitory Sequences
Table Major Players of Gene Transfer Therapy
Table Major Players of Nucleoside Analogs
Table Major Players of Ribozymes
Table Major Players of Aptamers
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Nucleic Acid-based Therapeutics Market Size Market Share by Type (2013-2018)
Figure Global Nucleic Acid-based Therapeutics Market Size Market Share by Type (2013-2018)
Figure Global Anti-Sense And Anti-Gene Market Size Growth Rate
Figure Global Short Inhibitory Sequences Market Size Growth Rate
Figure Global Gene Transfer Therapy Market Size Growth Rate
Figure Global Nucleoside Analogs Market Size Growth Rate
Figure Global Ribozymes Market Size Growth Rate
Figure Global Aptamers Market Size Growth Rate
Figure Nucleic Acid-based Therapeutics Consumed in Monogenetic Disorders
Figure Global Nucleic Acid-based Therapeutics Market: Monogenetic Disorders (2013-2018) ($ Millions)
Figure Global Monogenetic Disorders YoY Growth ($ Millions)
Figure Nucleic Acid-based Therapeutics Consumed in Multi-Genetic Disorders
Figure Global Nucleic Acid-based Therapeutics Market: Multi-Genetic Disorders (2013-2018) ($ Millions)
Figure Global Multi-Genetic Disorders YoY Growth ($ Millions)
Table Global Nucleic Acid-based Therapeutics Market Size by Application (2013-2018) ($ Millions)
Table Global Nucleic Acid-based Therapeutics Market Size Market Share by Application (2013-2018)
Figure Global Nucleic Acid-based Therapeutics Market Size Market Share by Application (2013-2018)
Figure Global Nucleic Acid-based Therapeutics Market Size in Monogenetic Disorders Growth Rate
Figure Global Nucleic Acid-based Therapeutics Market Size in Multi-Genetic Disorders Growth Rate
Table Global Nucleic Acid-based Therapeutics Revenue by Players (2016-2018) ($ Millions)
Table Global Nucleic Acid-based Therapeutics Revenue Market Share by Players (2016-2018)
Figure Global Nucleic Acid-based Therapeutics Revenue Market Share by Players in 2017
Table Global Nucleic Acid-based Therapeutics Key Players Head office and Products Offered
Table Nucleic Acid-based Therapeutics Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Nucleic Acid-based Therapeutics Market Size by Regions 2013-2018 ($ Millions)
Table Global Nucleic Acid-based Therapeutics Market Size Market Share by Regions 2013-2018
Figure Global Nucleic Acid-based Therapeutics Market Size Market Share by Regions 2013-2018
Figure Americas Nucleic Acid-based Therapeutics Market Size 2013-2018 ($ Millions)
Figure APAC Nucleic Acid-based Therapeutics Market Size 2013-2018 ($ Millions)
Figure Europe Nucleic Acid-based Therapeutics Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Nucleic Acid-based Therapeutics Market Size 2013-2018 ($ Millions)
Table Americas Nucleic Acid-based Therapeutics Market Size by Countries (2013-2018) ($ Millions)
Table Americas Nucleic Acid-based Therapeutics Market Size Market Share by Countries (2013-2018)
Figure Americas Nucleic Acid-based Therapeutics Market Size Market Share by Countries in 2017
Table Americas Nucleic Acid-based Therapeutics Market Size by Type (2013-2018) ($ Millions)
Table Americas Nucleic Acid-based Therapeutics Market Size Market Share by Type (2013-2018)
Figure Americas Nucleic Acid-based Therapeutics Market Size Market Share by Type in 2017
Table Americas Nucleic Acid-based Therapeutics Market Size by Application (2013-2018) ($ Millions)
Table Americas Nucleic Acid-based Therapeutics Market Size Market Share by Application (2013-2018)
Figure Americas Nucleic Acid-based Therapeutics Market Size Market Share by Application in 2017
Figure United States Nucleic Acid-based Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Canada Nucleic Acid-based Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Nucleic Acid-based Therapeutics Market Size Growth 2013-2018 ($ Millions)
Table APAC Nucleic Acid-based Therapeutics Market Size by Countries (2013-2018) ($ Millions)
Table APAC Nucleic Acid-based Therapeutics Market Size Market Share by Countries (2013-2018)
Figure APAC Nucleic Acid-based Therapeutics Market Size Market Share by Countries in 2017
Table APAC Nucleic Acid-based Therapeutics Market Size by Type (2013-2018) ($ Millions)
Table APAC Nucleic Acid-based Therapeutics Market Size Market Share by Type (2013-2018)
Figure APAC Nucleic Acid-based Therapeutics Market Size Market Share by Type in 2017
Table APAC Nucleic Acid-based Therapeutics Market Size by Application (2013-2018) ($ Millions)
Table APAC Nucleic Acid-based Therapeutics Market Size Market Share by Application (2013-2018)
Figure APAC Nucleic Acid-based Therapeutics Market Size Market Share by Application in 2017
Figure China Nucleic Acid-based Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Japan Nucleic Acid-based Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Korea Nucleic Acid-based Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Nucleic Acid-based Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure India Nucleic Acid-based Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Australia Nucleic Acid-based Therapeutics Market Size Growth 2013-2018 ($ Millions)
Table Europe Nucleic Acid-based Therapeutics Market Size by Countries (2013-2018) ($ Millions)
Table Europe Nucleic Acid-based Therapeutics Market Size Market Share by Countries (2013-2018)
Figure Europe Nucleic Acid-based Therapeutics Market Size Market Share by Countries in 2017
Table Europe Nucleic Acid-based Therapeutics Market Size by Type (2013-2018) ($ Millions)
Table Europe Nucleic Acid-based Therapeutics Market Size Market Share by Type (2013-2018)
Figure Europe Nucleic Acid-based Therapeutics Market Size Market Share by Type in 2017
Table Europe Nucleic Acid-based Therapeutics Market Size by Application (2013-2018) ($ Millions)
Table Europe Nucleic Acid-based Therapeutics Market Size Market Share by Application (2013-2018)
Figure Europe Nucleic Acid-based Therapeutics Market Size Market Share by Application in 2017
Figure Germany Nucleic Acid-based Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure France Nucleic Acid-based Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure UK Nucleic Acid-based Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Italy Nucleic Acid-based Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Russia Nucleic Acid-based Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Spain Nucleic Acid-based Therapeutics Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Nucleic Acid-based Therapeutics Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Nucleic Acid-based Therapeutics Market Size Market Share by Countries in 2017
Table Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Nucleic Acid-based Therapeutics Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Nucleic Acid-based Therapeutics Market Size Market Share by Type in 2017
Table Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Nucleic Acid-based Therapeutics Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Nucleic Acid-based Therapeutics Market Size Market Share by Application in 2017
Figure Egypt Nucleic Acid-based Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Nucleic Acid-based Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Israel Nucleic Acid-based Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Nucleic Acid-based Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Nucleic Acid-based Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Global Nucleic Acid-based Therapeutics arket Size Forecast (2018-2023) ($ Millions)
Table Global Nucleic Acid-based Therapeutics Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Nucleic Acid-based Therapeutics Market Size Market Share Forecast by Regions
Figure Americas Nucleic Acid-based Therapeutics Market Size 2018-2023 ($ Millions)
Figure APAC Nucleic Acid-based Therapeutics Market Size 2018-2023 ($ Millions)
Figure Europe Nucleic Acid-based Therapeutics Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Nucleic Acid-based Therapeutics Market Size 2018-2023 ($ Millions)
Figure United States Nucleic Acid-based Therapeutics Market Size 2018-2023 ($ Millions)
Figure Canada Nucleic Acid-based Therapeutics Market Size 2018-2023 ($ Millions)
Figure Mexico Nucleic Acid-based Therapeutics Market Size 2018-2023 ($ Millions)
Figure Brazil Nucleic Acid-based Therapeutics Market Size 2018-2023 ($ Millions)
Figure China Nucleic Acid-based Therapeutics Market Size 2018-2023 ($ Millions)
Figure Japan Nucleic Acid-based Therapeutics Market Size 2018-2023 ($ Millions)
Figure Korea Nucleic Acid-based Therapeutics Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Nucleic Acid-based Therapeutics Market Size 2018-2023 ($ Millions)
Figure India Nucleic Acid-based Therapeutics Market Size 2018-2023 ($ Millions)
Figure Australia Nucleic Acid-based Therapeutics Market Size 2018-2023 ($ Millions)
Figure Germany Nucleic Acid-based Therapeutics Market Size 2018-2023 ($ Millions)
Figure France Nucleic Acid-based Therapeutics Market Size 2018-2023 ($ Millions)
Figure UK Nucleic Acid-based Therapeutics Market Size 2018-2023 ($ Millions)
Figure Italy Nucleic Acid-based Therapeutics Market Size 2018-2023 ($ Millions)
Figure Russia Nucleic Acid-based Therapeutics Market Size 2018-2023 ($ Millions)
Figure Spain Nucleic Acid-based Therapeutics Market Size 2018-2023 ($ Millions)
Figure Egypt Nucleic Acid-based Therapeutics Market Size 2018-2023 ($ Millions)
Figure South Africa Nucleic Acid-based Therapeutics Market Size 2018-2023 ($ Millions)
Figure Israel Nucleic Acid-based Therapeutics Market Size 2018-2023 ($ Millions)
Figure Turkey Nucleic Acid-based Therapeutics Market Size 2018-2023 ($ Millions)
Figure GCC Countries Nucleic Acid-based Therapeutics Market Size 2018-2023 ($ Millions)
Table Global Nucleic Acid-based Therapeutics Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Nucleic Acid-based Therapeutics Market Size Market Share Forecast by Type (2018-2023)
Table Global Nucleic Acid-based Therapeutics Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Nucleic Acid-based Therapeutics Market Size Market Share Forecast by Application (2018-2023)
Table Wave Life Sciences Basic Information, Head Office, Major Market Areas and Its Competitors
Table Wave Life Sciences Nucleic Acid-based Therapeutics Revenue and Gross Margin (2016-2018)
Figure Wave Life Sciences Nucleic Acid-based Therapeutics Market Share (2016-2018)
Table Imugene Basic Information, Head Office, Major Market Areas and Its Competitors
Table Imugene Nucleic Acid-based Therapeutics Revenue and Gross Margin (2016-2018)
Figure Imugene Nucleic Acid-based Therapeutics Market Share (2016-2018)
Table Caperna Basic Information, Head Office, Major Market Areas and Its Competitors
Table Caperna Nucleic Acid-based Therapeutics Revenue and Gross Margin (2016-2018)
Figure Caperna Nucleic Acid-based Therapeutics Market Share (2016-2018)
Table Phylogica Basic Information, Head Office, Major Market Areas and Its Competitors
Table Phylogica Nucleic Acid-based Therapeutics Revenue and Gross Margin (2016-2018)
Figure Phylogica Nucleic Acid-based Therapeutics Market Share (2016-2018)
Table Protagonist Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Protagonist Therapeutics Nucleic Acid-based Therapeutics Revenue and Gross Margin (2016-2018)
Figure Protagonist Therapeutics Nucleic Acid-based Therapeutics Market Share (2016-2018)
Table Benitec Biopharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table Benitec Biopharma Nucleic Acid-based Therapeutics Revenue and Gross Margin (2016-2018)
Figure Benitec Biopharma Nucleic Acid-based Therapeutics Market Share (2016-2018)
Table EGEN Basic Information, Head Office, Major Market Areas and Its Competitors
Table EGEN Nucleic Acid-based Therapeutics Revenue and Gross Margin (2016-2018)
Figure EGEN Nucleic Acid-based Therapeutics Market Share (2016-2018)
Table BioMedica Basic Information, Head Office, Major Market Areas and Its Competitors
Table BioMedica Nucleic Acid-based Therapeutics Revenue and Gross Margin (2016-2018)
Figure BioMedica Nucleic Acid-based Therapeutics Market Share (2016-2018)
Table Transgene Basic Information, Head Office, Major Market Areas and Its Competitors
Table Transgene Nucleic Acid-based Therapeutics Revenue and Gross Margin (2016-2018)
Figure Transgene Nucleic Acid-based Therapeutics Market Share (2016-2018)
Table Copernicus Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Copernicus Therapeutics Nucleic Acid-based Therapeutics Revenue and Gross Margin (2016-2018)
Figure Copernicus Therapeutics Nucleic Acid-based Therapeutics Market Share (2016-2018)